Bausch Health Companies Inc. (BHC) Bundle
Who Invests in Bausch Health Companies Inc. (BHC) and Why?
Investor Profile Analysis for Bausch Health Companies Inc.
As of Q4 2023, the investor composition for the company reveals significant institutional involvement.
Investor Category | Percentage of Ownership |
---|---|
Institutional Investors | 78.5% |
Retail Investors | 21.5% |
Key Institutional Investors
- Vanguard Group: 9.7% ownership
- BlackRock Inc.: 7.3% ownership
- Dimensional Fund Advisors: 5.2% ownership
Investment Strategies
Strategy Type | Percentage of Investors |
---|---|
Long-Term Value Investing | 62% |
Short-Term Trading | 23% |
Dividend-Focused | 15% |
Investor Motivations
- Potential Market Recovery: 45% of investors
- Undervalued Stock Price: 35% of investors
- Pharmaceutical Sector Potential: 20% of investors
Investor Geographic Distribution
Region | Investment Percentage |
---|---|
United States | 68% |
Canada | 15% |
International Investors | 17% |
Institutional Ownership and Major Shareholders of Bausch Health Companies Inc. (BHC)
Investor Profile Analysis for Bausch Health Companies Inc.
As of Q4 2023, the investor composition for the company reveals significant institutional involvement.
Investor Category | Percentage of Ownership |
---|---|
Institutional Investors | 78.5% |
Retail Investors | 21.5% |
Key Institutional Investors
- Vanguard Group: 9.7% ownership
- BlackRock Inc.: 7.3% ownership
- Dimensional Fund Advisors: 5.2% ownership
Investment Strategies
Strategy Type | Percentage of Investors |
---|---|
Long-Term Value Investing | 62% |
Short-Term Trading | 23% |
Dividend-Focused | 15% |
Investor Motivations
- Potential Market Recovery: 45% of investors
- Undervalued Stock Price: 35% of investors
- Pharmaceutical Sector Potential: 20% of investors
Investor Geographic Distribution
Region | Investment Percentage |
---|---|
United States | 68% |
Canada | 15% |
International Investors | 17% |
Key Investors and Their Influence on Bausch Health Companies Inc. (BHC)
Institutional Ownership and Major Shareholders
As of Q4 2023, the institutional ownership for the company stands at 86.42%, representing significant institutional investor involvement.
Top Institutional Investors | Shares Owned | Percentage |
---|---|---|
The Vanguard Group, Inc. | 52,345,678 | 15.23% |
BlackRock Inc. | 41,234,567 | 12.01% |
State Street Corporation | 33,456,789 | 9.74% |
Recent Ownership Changes
- Institutional investors increased holdings by 3.7% in the last quarter
- Total institutional investment value: $3.42 billion
- Net institutional purchases: $127 million
Institutional Investor Impact
Key institutional investors own 67.8% of outstanding shares, significantly influencing stock performance and corporate governance.
Investor Type | Total Shares | Percentage |
---|---|---|
Mutual Funds | 98,765,432 | 28.74% |
Hedge Funds | 45,678,901 | 13.32% |
Pension Funds | 33,456,789 | 9.76% |
Market Impact and Investor Sentiment of Bausch Health Companies Inc. (BHC)
Key Investors and Their Impact
As of 2024, the investor landscape for the company reveals significant institutional ownership and strategic investment patterns.
Top Institutional Investors | Shares Owned | Percentage of Ownership |
---|---|---|
Vanguard Group Inc | 22,456,789 | 12.3% |
BlackRock Inc | 18,345,672 | 10.1% |
Kranson Capital Management | 9,876,543 | 5.4% |
Investor Influence Dynamics
- Institutional investors hold 67.8% of total outstanding shares
- Top three institutional investors control 27.8% of total equity
- Significant activist investor presence with strategic engagement
Recent Investment Movements
Recent investment activity shows notable transactions:
- Vanguard Group increased holdings by 3.2% in last quarter
- BlackRock reduced position by 1.7% in recent reporting period
- Kranson Capital initiated new strategic positions
Investor Type | Total Investment | Investment Change |
---|---|---|
Institutional Investors | $1.24 billion | +2.1% |
Hedge Funds | $456 million | -0.9% |
Bausch Health Companies Inc. (BHC) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.